These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9797240)

  • 1. Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans.
    Piccolomini R; Catamo G; Di Bonaventura G
    Antimicrob Agents Chemother; 1998 Nov; 42(11):3000-1. PubMed ID: 9797240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin.
    Piccolomini R; Di Bonaventura G; Catamo G; Picciani C; Paolantonio M
    Oral Microbiol Immunol; 1997 Dec; 12(6):366-71. PubMed ID: 9573812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of biotypes and antimicrobial susceptibility of Actinobacillus actinomycetemcomitans.
    Avila-Campos MJ; Carvalho MA; Zelante F
    Oral Microbiol Immunol; 1995 Dec; 10(6):382-4. PubMed ID: 8602348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobile rRNA methylase genes coding for erythromycin resistance in Actinobacillus actinomycetemcomitans.
    Roe DE; Weinberg A; Roberts MC
    J Antimicrob Chemother; 1996 Mar; 37(3):457-64. PubMed ID: 9182102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.
    Pavicić MJ; van Winkelhoff AJ; de Graaff J
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2634-8. PubMed ID: 1482130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial activity of new-quinolone and macrolide antibiotics against oral bacteria].
    Eguchi T; Shimizu Y; Furuhata K; Fukuyama M
    Kansenshogaku Zasshi; 2002 Nov; 76(11):939-45. PubMed ID: 12508477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
    Ednie LM; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.
    Miyake Y; Tsuruda K; Okuda K; Widowati ; Iwamoto Y; Suginaka H
    J Periodontal Res; 1995 Jul; 30(4):290-3. PubMed ID: 7562327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae.
    Welsh L; Gaydos C; Quinn TC
    Antimicrob Agents Chemother; 1996 Jan; 40(1):212-4. PubMed ID: 8787907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
    Berry V; Thorburn CE; Knott SJ; Woodnutt G
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3193-9. PubMed ID: 9835514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antibacterial activity of herbal extracts with antibiotics on bacteria responsible for periodontitis.
    Abullais Saquib S; Abdullah AlQahtani N; Ahmad I; Arora S; Mohammed Asif S; Ahmed Javali M; Nisar N
    J Infect Dev Ctries; 2021 Nov; 15(11):1685-1693. PubMed ID: 34898497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics.
    Müller HP; Holderrieth S; Burkhardt U; Höffler U
    J Clin Periodontol; 2002 Aug; 29(8):736-42. PubMed ID: 12390570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.
    Credito KL; Lin G; Pankuch GA; Bajaksouzian S; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2001 Jan; 45(1):67-72. PubMed ID: 11120946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
    Samra Z; Rosenberg S; Soffer Y; Dan M
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the E test for antimicrobial susceptibility testing of Actinobacillus actinomycetemcomitans.
    Pajukanta R; Asikainen S; Saarela M; Alaluusua S; Jousimies-Somer H
    Oral Microbiol Immunol; 1992 Dec; 7(6):376-7. PubMed ID: 1299801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected dietary (poly)phenols inhibit periodontal pathogen growth and biofilm formation.
    Shahzad M; Millhouse E; Culshaw S; Edwards CA; Ramage G; Combet E
    Food Funct; 2015 Mar; 6(3):719-29. PubMed ID: 25585200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of different Actinobacillus actinomycetemcomitans strains to lactoperoxidase-iodide-hydrogen peroxide combination and different antibiotics.
    Ihalin R; Pienihäkkinen K; Lenander M; Tenovuo J; Jousimies-Somer H
    Int J Antimicrob Agents; 2003 May; 21(5):434-40. PubMed ID: 12727076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans.
    Pajukanta R; Asikainen S; Saarela M; Alaluusua S; Jousimies-Somer H
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1241-3. PubMed ID: 1329617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.